⌘K
t
BioPharma Credit PLC will announce its Half Year Results for the period ending 30 June 2025 on Monday 22 September 2025. A management presentation will be delivered at 14.00 BST through a webcast facility.
| Date | 26 Aug 2025 |
| Time | 07:00:14 |
| Category | Results |
| ID | 5105W |
26
August 2025
BIOPHARMA CREDIT PLC
(the "Company")
NOTICE OF HALF YEAR RESULTS
BioPharma Credit PLC (LSE: BPCR), the specialist life sciences debt investor, will announce its Half Year Results for the period ending 30 June 2025 on Monday 22 September 2025.
A management presentation will be delivered at 14.00 BST through a webcast facility. To register to attend or request details, RSVP to biopharmacredit@buchanan.uk.com.
-Ends-
Enquiries:
BioPharma Credit plc
via MUFG Corporate Governance Limited
Company Secretary
+44 (0) 333 300 1932
Burson Buchanan
Mark Court / Jamie Hooper / Henry Wilson / Nick Croysdill
+44 (0)20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor in debt from the life sciences industry and joined the LSE on 27 March 2017. The Company seeks to provide long-term shareholder returns, principally in the form of sustainable income distributions from exposure to the life sciences industry. The Company seeks to achieve this objective primarily through investments in debt assets secured by royalties or other cash flows derived from the sales of approved life sciences products.